<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Flecainid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:54 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Flecainid_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Flecainid_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Flecainid_files/filelist.xml">
<title>FLECAINID</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:Created>2006-08-08T14:05:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:05:00Z</o:LastSaved>
  <o:Pages>5</o:Pages>
  <o:Words>1291</o:Words>
  <o:Characters>7361</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>61</o:Lines>
  <o:Paragraphs>17</o:Paragraphs>
  <o:CharactersWithSpaces>8635</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:normal'><span
style='font-size:15.0pt'>FLECAINID<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=MsoHeading7 align=left style='text-align:left'><b><span
style='font-size:14.0pt;font-style:normal'>Tên chung qu&#7889;c t&#7871;: </span></b><span
style='font-size:14.0pt;font-style:normal'>Flecainide.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><b><span
style='font-size:14.0pt'>Mã ATC: </span></b><span style='font-size:14.0pt'>C01B
C04.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><b><span
style='font-size:14.0pt'>Lo&#7841;i thu&#7889;c: </span></b><span
style='font-size:14.0pt'>Thu&#7889;c ch&#7889;ng lo&#7841;n nh&#7883;p.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Viên nén: 50 mg, 100 mg, 150 mg (d&#7841;ng flecainid
acetat).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Flecainid có tác d&#7909;ng gây tê và thu&#7897;c nhóm
thu&#7889;c ch&#7889;ng lo&#7841;n nh&#7883;p &#7893;n &#273;&#7883;nh màng
(nhóm1); thu&#7889;c có tác d&#7909;ng &#273;i&#7879;n sinh lý &#273;&#7863;c
tr&#432;ng ch&#7889;ng lo&#7841;n nh&#7883;p nhóm 1C. Tác d&#7909;ng ch&#7911;
y&#7871;u c&#7911;a flecainid là &#7913;c ch&#7871; dòng Na<sup>+</sup> nhanh
trong pha 0 c&#7911;a &#273;i&#7879;n th&#7871; ho&#7841;t &#273;&#7897;ng.
Flecainid kéo dài kho&#7843;ng AH, HV, PR, và QRS, và kéo dài th&#7901;i k&#7923;
tr&#417; h&#7919;u hi&#7879;u trong c&#417; th&#7845;t. Tác d&#7909;ng &#273;i&#7879;n
sinh lý làm kéo dài kho&#7843;ng QTc, ch&#7911; y&#7871;u do kéo dài QRS.
Flecainid kéo dài th&#7901;i gian d&#7851;n truy&#7873;n và giai &#273;o&#7841;n
tr&#417; h&#7919;u hi&#7879;u trong nh&#7919;ng &#273;&#432;&#7901;ng d&#7851;n
ph&#7909; &#7903; ng&#432;&#7901;i b&#7879;nh có nh&#7883;p tim nhanh trên th&#7845;t,
liên k&#7871;t v&#7899;i h&#7897;i ch&#7913;ng Wolff - Parkinson - White. Gi&#7889;ng
nh&#432; t&#7845;t c&#7843; nh&#7919;ng thu&#7889;c ch&#7889;ng lo&#7841;n nh&#7883;p
nhóm 1 khác, flecainid có tác d&#7909;ng gi&#7843;m l&#7921;c co c&#417; tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Flecainid acetat &#273;&#432;&#7907;c h&#7845;p thu
nhanh và nhi&#7873;u (70 ± 11%) qua &#273;&#432;&#7901;ng tiêu hóa. T&#7889;c
&#273;&#7897; h&#7845;p thu h&#417;i gi&#7843;m khi có th&#7913;c &#259;n. Ð&#7841;t
n&#7891;ng &#273;&#7897; &#273;&#7881;nh huy&#7871;t t&#432;&#417;ng trong vòng
2 - 3 gi&#7901;. Có th&#7875; c&#7847;n n&#7891;ng &#273;&#7897; huy&#7871;t t&#432;&#417;ng
0,2 &#273;&#7871;n 1,0 microgam/ml &#273;&#7875; &#273;&#7841;t hi&#7879;u qu&#7843;
&#273;i&#7873;u tr&#7883; t&#7889;i &#273;a. N&#7891;ng &#273;&#7897; huy&#7871;t
t&#432;&#417;ng trên 0,7 - 1,0 microgam/ml có t&#7927; l&#7879; tác d&#7909;ng
không mong mu&#7889;n cao v&#7873; tim nh&#432; r&#7889;i lo&#7841;n v&#7873; d&#7851;n
truy&#7873;n ho&#7863;c nh&#7883;p tim ch&#7853;m.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Flecainid &#273;&#432;&#7907;c phân b&#7889; nhanh và
r&#7897;ng; th&#7875; tích phân b&#7889; là 4,9 ± 0,4 lít/kg. G&#7855;n v&#7899;i
protein &#7903; m&#7913;c &#273;&#7897; v&#7915;a: 61 ± 10%. N&#7917;a &#273;&#7901;i
là 11 ± 3 gi&#7901;. Flecainid chuy&#7875;n hóa nhi&#7873;u &#7903; gan. Th&#7843;i
tr&#7915; qua n&#432;&#7899;c ti&#7875;u: 43 ± 3%. Ð&#7897; thanh th&#7843;i:
5,6 ± 1,3 ml/phút/kg. Th&#7843;i tr&#7915; qua phân: 5%. <o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>D&#7921; phòng và &#273;i&#7873;u tr&#7883; các lo&#7841;n
nh&#7883;p th&#7845;t nhanh &#273;e d&#7885;a &#273;&#7901;i s&#7889;ng (nh&#432;
nh&#7883;p nhanh th&#7845;t kéo dài). D&#7921; phòng và &#273;i&#7873;u tr&#7883;
c&#417;n nhanh k&#7883;ch phát trên th&#7845;t không &#273;áp &#7913;ng v&#7899;i
nh&#7919;ng li&#7879;u pháp khác bao g&#7891;m h&#7897;i ch&#7913;ng Wolff -
Parkinson - White, rung nh&#297; ho&#7863;c cu&#7891;ng &#273;&#7897;ng nh&#297;
k&#7883;ch phát &#7903; ng&#432;&#7901;i không có b&#7879;nh tim th&#7921;c th&#7875;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Khi ch&#432;a &#273;&#7863;t máy t&#7841;o nh&#7883;p
th&#7845;t, ch&#7889;ng ch&#7881; &#273;&#7883;nh flecainid &#7903; ng&#432;&#7901;i
b&#7879;nh &#273;ã m&#7855;c ch&#7913;ng bl&#7889;c nh&#297; - th&#7845;t
&#273;&#7897; hai ho&#7863;c &#273;&#7897; ba, ng&#432;&#7901;i b&#7883; bl&#7889;c
hai bó, bl&#7889;c nhánh ph&#7843;i, và c&#7843; &#7903; ng&#432;&#7901;i có s&#7889;c
do tim, ho&#7863;c quá m&#7851;n v&#7899;i thu&#7889;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Ch&#7881; dùng flecainid &#273;&#7875; &#273;i&#7873;u
tr&#7883; lo&#7841;n nh&#7883;p th&#7845;t &#273;e d&#7885;a &#273;&#7901;i s&#7889;ng.
Vi&#7879;c ng&#7915;ng &#273;i&#7873;u tr&#7883; flecainid ph&#7843;i th&#7921;c
hi&#7879;n trong b&#7879;nh vi&#7879;n v&#7899;i s&#7921; theo dõi &#273;i&#7879;n
tâm &#273;&#7891; liên t&#7909;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Ð&#7875; gi&#7843;m thi&#7875;u nguy c&#417; gây lo&#7841;n
nh&#7883;p, ph&#7843;i theo dõi n&#7891;ng &#273;&#7897; thu&#7889;c trong huy&#7871;t
t&#432;&#417;ng và tránh n&#7891;ng &#273;&#7897; trên 1 microgam/ml. Ph&#7843;i
theo dõi &#273;i&#7879;n tâm &#273;&#7891; &#273;&#7875; &#273;ánh giá c&#7849;n
th&#7853;n tr&#432;&#7899;c m&#7895;i l&#7847;n &#273;i&#7873;u ch&#7881;nh li&#7873;u,
và tránh dùng &#273;&#7891;ng th&#7901;i nh&#7919;ng thu&#7889;c ch&#7889;ng lo&#7841;n
nh&#7883;p khác. Ði&#7873;u tr&#7883; b&#7857;ng flecainid ph&#7843;i &#273;&#432;&#7907;c
b&#7855;t &#273;&#7847;u trong b&#7879;nh vi&#7879;n v&#7899;i vi&#7879;c theo
dõi &#273;i&#7879;n tâm &#273;&#7891; &#7903; ng&#432;&#7901;i b&#7879;nh có nh&#7883;p
nhanh th&#7845;t kéo dài, có b&#7879;nh v&#7873; c&#7845;u trúc tim, suy tim
sung huy&#7871;t có tri&#7879;u ch&#7913;ng, lo&#7841;n ch&#7913;c n&#259;ng c&#417;
tim n&#7863;ng, lo&#7841;n ch&#7913;c n&#259;ng nút xoang, và v&#7899;i ng&#432;&#7901;i
b&#7879;nh chuy&#7875;n &#273;i&#7873;u tr&#7883; sang m&#7897;t thu&#7889;c ch&#7889;ng
lo&#7841;n nh&#7883;p khác. Ph&#7843;i dùng flecainid h&#7871;t s&#7913;c th&#7853;n
tr&#7885;ng &#7903; ng&#432;&#7901;i có h&#7897;i ch&#7913;ng b&#7879;nh xoang
(k&#7875; c&#7843; h&#7897;i ch&#7913;ng nh&#7883;p ch&#7853;m - nh&#7883;p
nhanh), vì thu&#7889;c có th&#7875; gây nh&#7883;p ch&#7853;m xoang, ng&#7915;ng
tim t&#7841;m th&#7901;i, ho&#7863;c ng&#7915;ng tim, &#7903; ng&#432;&#7901;i
có &#273;&#7863;t máy t&#7841;o nh&#7883;p th&#432;&#7901;ng xuyên, ho&#7863;c
&#273;i&#7879;n c&#7921;c t&#7841;o nh&#7883;p t&#7841;m th&#7901;i, và &#7903;
ng&#432;&#7901;i suy th&#7853;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>N&#7871;u m&#7845;t cân b&#7857;ng kali, ph&#7843;i hi&#7879;u
ch&#7881;nh tr&#432;&#7899;c khi dùng flecainid. Không dùng flecainid cho ng&#432;&#7901;i
b&#7883; suy gan n&#7863;ng, rung nh&#297; m&#7841;n tính, ho&#7863;c m&#7899;i
b&#7883; nh&#7891;i máu c&#417; tim.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Cho t&#7899;i nay ch&#432;a có công trình nghiên c&#7913;u
&#273;&#7847;y &#273;&#7911; và có ki&#7875;m ch&#7913;ng v&#7873; vi&#7879;c
dùng flecainid cho ng&#432;&#7901;i mang thai, tuy v&#7853;y theo nguyên t&#7855;c
chung, không dùng flecainid trong th&#7901;i k&#7923; mang thai.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Flecainid có phân b&#7889; trong s&#7919;a ng&#432;&#7901;i.
Vì có th&#7875; có nh&#7919;ng tác d&#7909;ng không mong mu&#7889;n nghiêm tr&#7885;ng
do flecainid gây ra &#7903; tr&#7867; nh&#7887; bú s&#7919;a m&#7865;, nên ph&#7843;i
cân nh&#7855;c xem ng&#7915;ng cho bú ho&#7863;c ng&#7915;ng thu&#7889;c, có
chú ý &#273;&#7871;n t&#7847;m quan tr&#7885;ng c&#7911;a thu&#7889;c &#273;&#7889;i
v&#7899;i ng&#432;&#7901;i m&#7865;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Tác d&#7909;ng không mong mu&#7889;n
(ADR) <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Lo&#7841;n nh&#7883;p th&#7845;t nghiêm tr&#7885;ng
&#273;ã x&#7843;y ra &#7903; ng&#432;&#7901;i suy tim, &#7903; ng&#432;&#7901;i
có nh&#7883;p nhanh th&#7845;t có tri&#7879;u ch&#7913;ng, &#273;&#7863;c bi&#7879;t
khi dùng li&#7873;u b&#7855;t &#273;&#7847;u và li&#7873;u duy trì cao, và &#7903;
ng&#432;&#7901;i có lo&#7841;n nh&#7883;p th&#7845;t không có tri&#7879;u ch&#7913;ng
sau nh&#7891;i máu c&#417; tim. Có th&#7875; gây bl&#7889;c nh&#297; th&#7845;t,
&#273;&#7863;c bi&#7879;t &#7903; ng&#432;&#7901;i có lo&#7841;n ch&#7913;c
n&#259;ng nút xoang. Li&#7879;u pháp v&#7899;i flecainid gây khó kh&#259;n
trong kh&#7917; rung &#7903; ng&#432;&#7901;i có nh&#7883;p nhanh th&#7845;t ho&#7863;c
cu&#7891;ng &#273;&#7897;ng (flutter) th&#7845;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Toàn thân: Ðau ng&#7921;c, m&#7879;t m&#7887;i, phù,
chóng m&#7863;t, nh&#7913;c &#273;&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tim m&#7841;ch: Lo&#7841;n nh&#7883;p th&#7845;t, bl&#7889;c
nh&#297; - th&#7845;t &#273;&#7897; I, &#273;ánh tr&#7889;ng ng&#7921;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Th&#7847;n kinh trung &#432;&#417;ng: Run, r&#7889;i
lo&#7841;n th&#7883; giác, &#273;i&#7873;u ti&#7871;t khó kh&#259;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tiêu hóa: Táo bón dai d&#7859;ng, &#273;au b&#7909;ng,
bu&#7891;n nôn.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Hô h&#7845;p: Khó th&#7903;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Th&#7847;n kinh: B&#7879;nh &#273;a dây th&#7847;n
kinh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tim m&#7841;ch: Nh&#7883;p tim ch&#7853;m, P - R, QRS
kéo dài, gây ho&#7863;c làm n&#7863;ng thêm suy tim sung huy&#7871;t, bl&#7889;c
nh&#297; - th&#7845;t &#273;&#7897; II và &#273;&#7897; III, &#273;au th&#7855;t
ng&#7921;c, t&#259;ng huy&#7871;t áp, h&#7841; huy&#7871;t áp.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Da: Mày &#273;ay, ng&#7913;a.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tiêu hóa: Ð&#7847;y h&#417;i, khô mi&#7879;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>M&#7855;t: Ðau &#7903; m&#7855;t, s&#7907; ánh sáng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>N&#7871;u nghi ng&#7901; ho&#7863;c xác &#273;&#7883;nh
là flecainid gây t&#259;ng t&#7847;n s&#7889; ngo&#7841;i tâm thu th&#7845;t
tuy dùng li&#7873;u thích h&#7907;p, ph&#7843;i dùng thu&#7889;c khác thay th&#7871;.
N&#7871;u x&#7843;y ra suy tim sung huy&#7871;t ti&#7871;n tri&#7875;n tuy
&#273;ã gi&#7843;m li&#7873;u flecainid, ph&#7843;i ng&#7915;ng thu&#7889;c
ngay. N&#7871;u các kho&#7843;ng PR, QRS và QT kéo dài nhi&#7873;u, và/ho&#7863;c
bl&#7889;c nhánh m&#7899;i phát tri&#7875;n trong khi &#273;i&#7873;u tr&#7883;
b&#7857;ng flecainid, c&#7847;n xem xét gi&#7843;m li&#7873;u. N&#7871;u x&#7843;y
ra bl&#7889;c nh&#297; - th&#7845;t &#273;&#7897; II ho&#7863;c III ho&#7863;c
bl&#7889;c hai bó, ph&#7843;i ng&#7915;ng thu&#7889;c tr&#7915; khi &#273;&#7863;t
t&#7841;m th&#7901;i ho&#7863;c c&#7845;y m&#7897;t máy t&#7841;o nh&#7883;p
&#273;&#7875; &#273;&#7843;m b&#7843;o t&#7847;n s&#7889; th&#7845;t thích h&#7907;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Ph&#7843;i ng&#7915;ng &#273;i&#7873;u tr&#7883; b&#7857;ng
flecainid &#7903; ng&#432;&#7901;i phát tri&#7875;n vàng da, có d&#7845;u hi&#7879;u
lo&#7841;n ch&#7913;c n&#259;ng gan, ho&#7863;c lo&#7841;n t&#7841;o máu &#273;&#7875;
lo&#7841;i tr&#7915; kh&#7843; n&#259;ng thu&#7889;c là nguyên nhân gây nên. Có
th&#7875; &#273;i&#7873;u tr&#7883; suy tim sung huy&#7871;t do flecainid gây
nên ho&#7863;c làm cho n&#7863;ng thêm b&#7857;ng thu&#7889;c digitalis ho&#7863;c
thu&#7889;c l&#7907;i ti&#7875;u.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Li&#7873;u l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Flecainid<i> </i>acetat &#273;&#432;&#7907;c dùng u&#7889;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Li&#7873;u th&#432;&#7901;ng dùng cho ng&#432;&#7901;i
l&#7899;n:<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Tr&#432;&#7901;ng h&#7907;p nh&#7883;p nhanh trên th&#7845;t
k&#7883;ch phát ho&#7863;c rung/cu&#7891;ng &#273;&#7897;ng tâm nh&#297; k&#7883;ch
phát: <o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>U&#7889;ng, 50 mg c&#7913; 12 gi&#7901; m&#7897;t l&#7847;n,
t&#259;ng li&#7873;u v&#7899;i l&#432;&#7907;ng t&#259;ng thêm 50 mg, ngày 2 l&#7847;n,
c&#7913; 4 ngày t&#259;ng m&#7897;t l&#7847;n theo s&#7921; c&#7847;n thi&#7871;t
và kh&#7843; n&#259;ng dung n&#7841;p và gi&#7843;m li&#7873;u m&#7897;t khi
&#273;&#7841;t &#273;&#432;&#7907;c k&#7871;t qu&#7843;; u&#7889;ng t&#7889;i
&#273;a 300 mg/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Tr&#432;&#7901;ng h&#7907;p nh&#7883;p nhanh th&#7845;t
kéo dài: <o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>B&#7855;t &#273;&#7847;u: U&#7889;ng 100 mg, c&#7913;
12 gi&#7901; m&#7897;t l&#7847;n, t&#259;ng li&#7873;u v&#7899;i l&#432;&#7907;ng
t&#259;ng thêm 50 mg, ngày 2 l&#7847;n, c&#7913; 4 ngày t&#259;ng m&#7897;t l&#7847;n
theo s&#7921; c&#7847;n thi&#7871;t và kh&#7843; n&#259;ng dung n&#7841;p; u&#7889;ng
t&#7889;i &#273;a 400 mg/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Li&#7873;u duy trì: Li&#7873;u t&#7889;i &#273;a 150
mg, cách 12 gi&#7901; m&#7897;t l&#7847;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Ghi chú:</span></i><span style='font-size:14.0pt'> V&#7899;i
ng&#432;&#7901;i b&#7879;nh b&#7883; suy th&#7853;n n&#7863;ng (&#273;&#7897;
thanh th&#7843;i creatinin: 35 ml/phút/1,73 m<sup>2</sup>), dùng li&#7873;u b&#7855;t
&#273;&#7847;u 100 mg, ngày m&#7897;t l&#7847;n, ho&#7863;c 50 mg, c&#7913; 12
gi&#7901; m&#7897;t l&#7847;n, và hi&#7879;u ch&#7881;nh li&#7873;u trên c&#417;
s&#7903; theo dõi xác &#273;&#7883;nh th&#432;&#7901;ng xuyên n&#7891;ng &#273;&#7897;
thu&#7889;c trong huy&#7871;t t&#432;&#417;ng. V&#7899;i ng&#432;&#7901;i b&#7879;nh
b&#7883; suy th&#7853;n nh&#7865; h&#417;n, dùng li&#7873;u b&#7855;t &#273;&#7847;u
100 mg c&#7913; 12 gi&#7901; m&#7897;t l&#7847;n; hi&#7879;u ch&#7881;nh li&#7873;u
trên c&#417; s&#7903; xác &#273;&#7883;nh n&#7891;ng &#273;&#7897; thu&#7889;c
trong huy&#7871;t t&#432;&#417;ng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Các ch&#7845;t t&#259;ng &#273;&#7897; acid n&#432;&#7899;c
ti&#7875;u có th&#7875; làm t&#259;ng th&#7843;i tr&#7915;, và các ch&#7845;t
t&#259;ng &#273;&#7897; ki&#7873;m n&#432;&#7899;c ti&#7875;u có th&#7875; làm
gi&#7843;m th&#7843;i tr&#7915; flecainid; có th&#7875; c&#7847;n ph&#7843;i hi&#7879;u
ch&#7881;nh li&#7873;u flecainid. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Dùng &#273;&#7891;ng th&#7901;i nh&#7919;ng thu&#7889;c
ch&#7889;ng lo&#7841;n nh&#7883;p khác v&#7899;i flecainid có th&#7875; gây tác
d&#7909;ng hi&#7879;p &#273;&#7891;ng trên tim; nh&#7883;p nhanh th&#7845;t/rung
th&#7845;t không h&#7891;i ph&#7909;c &#273;ã x&#7843;y ra &#7903; ng&#432;&#7901;i
có nh&#7883;p nhanh th&#7845;t có huy&#7871;t áp th&#7845;p. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Dùng &#273;&#7891;ng th&#7901;i amiodaron gây
t&#259;ng n&#7891;ng &#273;&#7897; flecainid trong huy&#7871;t t&#432;&#417;ng;
ph&#7843;i gi&#7843;m 50% li&#7873;u flecainid và theo dõi c&#7849;n th&#7853;n
n&#7891;ng &#273;&#7897; flecainid trong huy&#7871;t t&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Dùng &#273;&#7891;ng th&#7901;i các thu&#7889;c ch&#7865;n
beta v&#7899;i flecainid có th&#7875; gây tác d&#7909;ng hi&#7879;p &#273;&#7891;ng
gi&#7843;m l&#7921;c co c&#417;; ngoài ra, dùng &#273;&#7891;ng th&#7901;i
propranolol làm t&#259;ng n&#7891;ng &#273;&#7897; c&#7843; hai thu&#7889;c
trong huy&#7871;t t&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Dùng &#273;&#7891;ng th&#7901;i digoxin v&#7899;i flecainid
gây t&#259;ng nh&#7845;t th&#7901;i n&#7891;ng &#273;&#7897; digoxin trong huy&#7871;t
t&#432;&#417;ng; không th&#7845;y có tác d&#7909;ng không mong mu&#7889;n.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Ð&#7897; &#7893;n &#273;&#7883;nh và b&#7843;o
qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Viên nén flecainid &#273;&#432;&#7907;c b&#7843;o qu&#7843;n
trong l&#7885; kín &#7903; 15 - 30<sup>0</sup>C và tránh ánh sáng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Bi&#7875;u hi&#7879;n quá li&#7873;u</span></i><span
style='font-size:14.0pt'>: T&#259;ng các kho&#7843;ng PR, QRS, và QT và biên
&#273;&#7897; sóng T; gi&#7843;m t&#7847;n s&#7889; tim và l&#7921;c co c&#417;
tim; r&#7889;i lo&#7841;n d&#7851;n truy&#7873;n; h&#7841; huy&#7871;t áp; và
ch&#7871;t do suy hô h&#7845;p ho&#7863;c suy tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Ði&#7873;u tr&#7883;:</span></i><span
style='font-size:14.0pt'> Th&#432;&#7901;ng là &#273;i&#7873;u tr&#7883; tri&#7879;u
ch&#7913;ng và h&#7891;i s&#7913;c. Làm s&#7841;ch d&#7841; dày ngay b&#7857;ng
cách gây nôn ho&#7863;c r&#7917;a d&#7841; dày. Dùng than ho&#7841;t có th&#7875;
có thêm tác d&#7909;ng ng&#259;n c&#7843;n h&#7845;p thu flecainid. Ði&#7873;u
tr&#7883; h&#7891;i s&#7913;c g&#7891;m tiêm t&#297;nh m&#7841;ch thu&#7889;c
t&#259;ng l&#7921;c co c&#417; tim, ho&#7863;c kích thích tim (ví d&#7909;,
dopamin, dobutamin, isoproterenol), h&#7895; tr&#7907; tu&#7847;n hoàn, hô h&#7845;p
nhân t&#7841;o b&#7857;ng máy, và &#273;&#7863;t máy t&#7841;o nh&#7883;p tim
qua t&#297;nh m&#7841;ch. Vì flecainid có n&#7917;a &#273;&#7901;i th&#7843;i
tr&#7915; dài, c&#7847;n &#273;i&#7873;u tr&#7883; quá li&#7873;u trong th&#7901;i
gian dài.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal;
page-break-after:avoid;mso-outline-level:7'><span style='font-size:14.0pt'>Th&#7849;m
tách máu không ph&#7843;i là cách h&#7919;u hi&#7879;u &#273;&#7875; lo&#7841;i
flecainid ra kh&#7887;i c&#417; th&#7875;. Ðào th&#7843;i flecainid s&#7869; ch&#7853;m
h&#417;n n&#7871;u n&#432;&#7899;c ti&#7875;u r&#7845;t ki&#7873;m (pH b&#7857;ng
ho&#7863;c trên 8), vì v&#7853;y v&#7873; lý thuy&#7871;t, acid hóa n&#432;&#7899;c
ti&#7875;u &#273;&#7875; thúc &#273;&#7849;y &#273;ào th&#7843;i thu&#7889;c có
th&#7875; có hi&#7879;u qu&#7843; trong nh&#7919;ng tr&#432;&#7901;ng h&#7907;p
quá li&#7873;u có n&#432;&#7899;c ti&#7875;u r&#7845;t ki&#7873;m. Không có b&#7857;ng
ch&#7913;ng là acid hóa n&#432;&#7899;c ti&#7875;u có pH bình th&#432;&#7901;ng
làm t&#259;ng &#273;ào th&#7843;i thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Flecainid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:54 GMT -->
</html>
